Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. May 25, 2022; 11(3): 96-104
Published online May 25, 2022. doi: 10.5527/wjn.v11.i3.96
Published online May 25, 2022. doi: 10.5527/wjn.v11.i3.96
Liposoluble vitamins A and E in kidney disease
Maria Helena Rojo-Trejo, Ma Ludivina Robles-Osorio, Nutrition School, Universidad Autónoma de Querétaro, Querétaro 76910, Mexico
Ernesto Sabath, Department of Renal Medicine, Nutrition School, Universidad Autónoma de Querétaro, Querétaro 76090, Mexico
Author contributions: Rojo-Trejo MH, Robles-Osorio ML, and Sabath E were involved in the literature review; Robles-Osorio ML contributed to revising the article; Sabath E contributed to writing and drafting the article.
Conflict-of-interest statement: The authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ernesto Sabath, MD, PhD, Assistant Professor, Director, Department of Renal Medicine, Nutrition School, Universidad Autónoma de Querétaro, Fray Luis de León 1990, Querétaro 76090, Mexico. esabath@yahoo.com
Received: June 2, 2021
Peer-review started: June 2, 2021
First decision: July 31, 2021
Revised: August 15, 2021
Accepted: April 21, 2022
Article in press: April 21, 2022
Published online: May 25, 2022
Processing time: 355 Days and 22.2 Hours
Peer-review started: June 2, 2021
First decision: July 31, 2021
Revised: August 15, 2021
Accepted: April 21, 2022
Article in press: April 21, 2022
Published online: May 25, 2022
Processing time: 355 Days and 22.2 Hours
Core Tip
Core Tip: Oxidative stress in patients with kidney disease (KD) is an important risk factor for cardiovascular disease. Vitamin A and E are important antioxidants with many roles in health and KD. High levels of vitamin A may have adverse health effects but higher levels of vitamin E have been associated with a lower overall mortality. Exogenous administration of these vitamins to patients with KD have shown controversial results.